- Home
- OII vs DNLI Comparison
OII vs DNLI Comparison
Compare OII & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OII
- DNLI
- Stock Information
- Founded
- OII 1964
- DNLI 2013
- Country
- OII United States
- DNLI United States
- Employees
- OII N/A
- DNLI N/A
- Industry
- OII Oilfield Services/Equipment
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OII Energy
- DNLI Health Care
- Exchange
- OII Nasdaq
- DNLI Nasdaq
- Market Cap
- OII 1.9B
- DNLI 2.1B
- IPO Year
- OII N/A
- DNLI 2017
- Fundamental
- Price
- OII $21.43
- DNLI $13.75
- Analyst Decision
- OII Hold
- DNLI Strong Buy
- Analyst Count
- OII 5
- DNLI 15
- Target Price
- OII $28.00
- DNLI $33.85
- AVG Volume (30 Days)
- OII 670.5K
- DNLI 1.6M
- Earning Date
- OII 07-23-2025
- DNLI 07-31-2025
- Dividend Yield
- OII N/A
- DNLI N/A
- EPS Growth
- OII 67.93
- DNLI N/A
- EPS
- OII 1.78
- DNLI N/A
- Revenue
- OII $2,736,592,000.00
- DNLI N/A
- Revenue This Year
- OII $4.92
- DNLI N/A
- Revenue Next Year
- OII $3.22
- DNLI $335.74
- P/E Ratio
- OII $12.12
- DNLI N/A
- Revenue Growth
- OII 10.04
- DNLI N/A
- 52 Week Low
- OII $15.46
- DNLI $10.57
- 52 Week High
- OII $30.98
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- OII 66.97
- DNLI 45.12
- Support Level
- OII $20.57
- DNLI $13.68
- Resistance Level
- OII $22.09
- DNLI $14.88
- Average True Range (ATR)
- OII 0.71
- DNLI 0.74
- MACD
- OII 0.14
- DNLI -0.03
- Stochastic Oscillator
- OII 85.29
- DNLI 34.91
About OII Oceaneering International Inc.
Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.